Human BACE2 knockout SW480 cell line
Be the first to review this product! Submit a review
|
(0 Publication)
BACE2 KO cell line available to order. KO validated by Next Generation Sequencing. Free of charge wild type control provided. Knockout achieved by CRISPR/Cas9 X = 1 bp deletion Frameshift: 100%.
View Alternative Names
ALP 56, ASP21, Asp 1, Aspartic-like protease 56 kDa, Aspartyl protease 1, BACE2_HUMAN, Beta Site Amyloid Beta A4 Precursor Protein Cleaving Enzyme 2, Beta-secretase 2, Beta-site APP cleaving enzyme 2, Beta-site amyloid precursor protein cleaving enzyme 2, DRAP, Down region aspartic protease, Downs Syndrome Region Aspartic Protease, Memapsin-1, Membrane-associated aspartic protease 1, Theta-secretase
- NGS
Supplier Data
Next Generation Sequencing - Human BACE2 knockout SW480 cell line (AB269622)
Knockout achieved by CRISPR/Cas9; X = 1 bp deletion; Frameshift : 100%
Reactivity data
Product details
Recommended control: Human wild-type SW480 cell line (ab271146). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.
We will provide viable cells that proliferate on revival.
This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.
What's included?
Properties and storage information
Gene name
Gene editing type
Gene editing method
Knockout validation
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Handling procedures
Initial handling guidelines
Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.
1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.
Subculture guidelines
- All seeding densities should be based on cell counts gained by established methods.
- A guide seeding density of 2-3x104 cells/cm2 is recommended.
- Cells should be passaged when they have achieved 80-90% confluence.
- Slow growing. A partial media change is recommended at least twice between passages.
Culture medium
Ham's F-12 + 10% FBS
Cryopreservation medium
Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
BACE2 acts on substrates to regulate amyloidogenic processing of APP. It belongs to the peptidase A1 Family. Unlike its counterpart BACE1 which promotes amyloid-beta peptide production BACE2 has been suggested to reduce amyloid-beta formation by different substrate cleavage. Though not part of a stable complex BACE2 influences pathways related to protein processing.
Pathways
One should note that BACE2 is involved in the amyloidogenic pathway. This pathway processes APP and affects amyloid-beta levels important in neurological conditions. BACE2 acts with proteins like APP and might modulate the effects seen due to BACE1 activity. Despite overlapping functions BACE2 and BACE1 have distinct roles in this pathway impacting amyloid levels differently.
Cell culture
Biosafety level
EU: 1 US: 1
Adherent/suspension
Adherent
Gender
Male
Target data
Complementary Products
Primary Antibodies
AB270458
Anti-BACE2 antibody [EPR23339-221]
BOND RX™ Validated|20ul selling size|RabMAb|Recombinant|Trial Size
![Western blot - Anti-BACE2 antibody [EPR23339-221] (AB270458)](https://content.abcam.com/products/images/bace2-antibody-epr23339-221-ab270458--western-blot-img418643.jpg)
- 3
- 2
![Western blot - Anti-p53 antibody [PAb 240] (AB26)](https://content.abcam.com/products/images/p53-antibody-pab-240-ab26--western-blot-img138717.jpg)
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com